Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

carDIo-ttranSSfOrm nucLEar Imaging Study

NCT05259072 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT05259072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05259072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
carDIo-ttranSSfOrm nucLEar Imaging Study
Lead sponsor
Oregon Health and Science University
Phase
Observational
Overall status
Terminated
Start date
January 19, 2022
Completion date
December 30, 2023
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis, transthyretin amyloid cardiomyopathy